Dymista, a nasal spray combining fluticasone propionate and azelastine hydrochloride, received FDA approval in the United States in 2014 [1]. This approval was for the treatment of nasal allergy symptoms in patients aged 12 and older [2].
What are the active ingredients in Dymista?
Dymista contains two active ingredients: fluticasone propionate, a corticosteroid, and azelastine hydrochloride, an antihistamine [1]. This combination is designed to target multiple inflammatory pathways involved in allergic rhinitis [2].
How does Dymista work?
Fluticasone propionate works by reducing inflammation in the nasal passages. Azelastine hydrochloride blocks the action of histamine, a chemical released by the body during an allergic reaction that causes symptoms like sneezing and itching [2].
When does Dymista's patent expire?
The patent expiration timeline for Dymista can be complex, often involving multiple patents covering different aspects of the drug, such as formulation and method of use. Information on specific patent expiry dates for Dymista can be found on specialized patent tracking websites like DrugPatentWatch.com [3].
Are there generic versions of Dymista available?
As of early 2024, generic versions of Dymista nasal spray are available in the market. The availability of generics typically follows patent expiries and the successful approval of Abbreviated New Drug Applications (ANDAs) by the FDA [3].
What are the common side effects of Dymista?
Common side effects reported with Dymista include headache, nosebleeds, and an unpleasant taste in the mouth [2]. These side effects are generally mild and temporary.
How does Dymista compare to other allergy nasal sprays?
Dymista is a combination product, offering both a corticosteroid and an antihistamine in a single spray. Other allergy nasal sprays may contain only one of these active ingredients or different types of medications. The choice of spray often depends on the severity and type of allergy symptoms [2].
Where can I find more information on Dymista's regulatory status?
Detailed information regarding Dymista's FDA approval, including its labeling and any post-market requirements, can be found on the U.S. Food and Drug Administration's official website.
Sources
1. Dymista Prescribing Information.
2. Dymista Nasal Spray. (n.d.). Retrieved from DrugPatentWatch.com
3. DrugPatentWatch.com.